Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report by Chen, Yuanbin, MD, PhD, Paz-Ares, Luis, MD, PhD, Reinmuth, Niels, MD, PhD, Garassino, Marina Chiara, MD, Statsenko, Galina, MD, Hochmair, Maximilian J., MD, Özgüroğlu, Mustafa, MD, PhD, Verderame, Francesco, MD, Havel, Libor, MD, Losonczy, György, MD, PhD, Conev, Nikolay V., MD, PhD, Hotta, Katsuyuki, MD, PhD, MPH, Ji, Jun Ho, MD, PhD, Spencer, Stuart, MSc, Dalvi, Tapashi, PhD, MPH, Jiang, Haiyi, MD, Goldman, Jonathan W., MD

Get full text

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updat... by Goldman, Jonathan W, MD, Dvorkin, Mikhail, MD, Chen, Yuanbin, MD, Reinmuth, Niels, MD, Hotta, Katsuyuki, Prof, Trukhin, Dmytro, MD, Statsenko, Galina, MD, Hochmair, Maximilian J, MD, Özgüroğlu, Mustafa, Prof, Ji, Jun Ho, MD, Garassino, Marina Chiara, MD, Voitko, Oleksandr, MD, Poltoratskiy, Artem, MD, Ponce, Santiago, MD, Verderame, Francesco, MD, Havel, Libor, MD, Bondarenko, Igor, Prof, Każarnowicz, Andrzej, MD, Losonczy, György, Prof, Conev, Nikolay V, MD, Armstrong, Jon, MSc, Byrne, Natalie, BSc, Thiyagarajah, Piruntha, MD, Jiang, Haiyi, MD, Paz-Ares, Luis, Prof

Get full text